Table 6.
Comparison of the clinical outcomes between the current and published studies from different geographic areas
| Year | Country | Sample size | Mean age | DM | Transfer to HD | Mortality | CRP type | Mean CRP (mg/L) | Predictor of dropout | Predictor of mortality |
|---|---|---|---|---|---|---|---|---|---|---|
| 199835 | Korea | 105 | 49.0 | 11.4% | ? | 2-year 8.6% | CRP | 6.5 (baseline) | No (baseline) | Yes (baseline) |
| 200139 | Australia | 50 | 63.0 | 20.0% | 3-year 10.0% | 3-year 56.0% | CRP | 8.0 (baseline) | – | No (baseline) |
| 200338 | Hong Kong | 246 | 55.0 | 30.9% | 2-year 9.3% | 2-year 24.0% | HS-CRP | 2.84 (baseline) | – | Yes (baseline) |
| 200529 | Turkey | 97 | 42.1 | ? | 3-year 14.4% | 3-year 18.6% | CRP | 7.2 (baseline) 8.0 (averaged) |
– | No (baseline) Yes (averaged) |
| 201040 | Korea | 187 | 54.0 | 56.7% | 6-year 18.1% | 6-year 31.6% | HS-CRP | ? | No (baseline) | No (baseline) |
| 201422 | Taiwan | 402 | 48.6 | 17.7% | 2-year 20.1% | 2-year 7.0% | HS-CRP | 9.57 (baseline) | Yes (baseline) | Yes (baseline) |
Abbreviations: DM, diabetes mellitus; HD, hemodialysis; CRP, C-reactive protein; HS-CRP, high-sensitivity C-reactive protein.